LawPlayer
My bookmarks
Source

2011/89/EU: Commission Decision of 8 February 2011 concerning a financial contribution by the Union to the Netherlands for studies on Q fever (notified under document C(2011) 554)

2011/89/EU: Commission Decision of 8 February 2011 concerning a financial contribution by the Union to the Netherlands for studies on Q fever (notified under document C(2011) 554)

Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   The Union shall grant the Netherlands financial assistance for their studies on Q fever, as summarised in the Annex. The present Decision constitutes a financing decision in the meaning of Article 75 of the Financial Regulation. 2.   The following conditions must be fulfilled: (a) the outcomes of the studies must be made available to the Commission and all Member States and presented at the Standing Committee on the Food Chain and Animal Health; (b) the Netherlands must forward a final technical and financial report to the Commission on 31 March 2012 at the latest, the financial report accompanied by supporting documents justifying evidence as to the costs incurred and the results attained.

Article 2

Open ↗

1.   The maximum contribution authorised by this Decision for the costs incurred for the work referred to in Article 1(1) is set at EUR 500 000 to be financed from the following Budgetary Line of the General Budget of the European Union for 2011: — Budgetary Line No 17 04 02 01: EUR 500 000. 2.   The Union’s financial assistance shall be paid following presentation of the reports and supporting documents referred to Article 1(2)(b).

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Description of the technical and scientific studies on the epidemiology of Q fever and the effectiveness of possible control measures applicable to domestic ruminants, referred to in Article 1(1) Project 1 : ‘Q fever in goats’ involves the cultivation of C. burnetii and the characterisation of C. burnetii of the different genotypes that exist in the Netherlands. It also involves the survival of C. burnetii in manure, the different infection routes, the development of immunity, the shedding of C. burnetii in pregnant and non-pregnant goats and general information on the pathogeneses of C. burnetii . Project 2 : ‘Assessment of the virulence of C. burnetii strains in goats’ addresses the question if the current Dutch strain in goats is more virulent than other C. burnetii strains. Project 3 : ‘Pathogeneses of Q fever’ studies the pathogenesis of C. burnetii infections in goats; the role of pregnancy in the pathogenesis of C. burnetii infections; the build up of cellular and humoral immunity; differences in virulence of C. burnetii strains in goats and the protective immunity of natural infection. With the knowledge of the pathogenesis and the within herd transmission, the results of diagnostic testing can better be understood. Project 4 : ‘Inventory of Q fever strains in cattle, sheep, dogs and cats’ studies the relation between Q fever human patients and possible animal sources. The aim is to compare Q fever strains found in different animal species with the strains found in human patients. This is important to be able to exclude animals other than dairy goats as a source of human infections. Project 5 : ‘Effectiveness of vaccination’ compares field studies previously carried out in particular in France with new field studies in the Netherlands to assess the effectiveness of vaccination of goats against Q fever. Project 6 : ‘Search for suitable means of disinfection’ aims at identifying suitable products for disinfection and to assess whether materials like wood, straw, ground and manure can be effectively disinfected. The project includes: (i) the definition of criteria for disinfection products; (ii) the inactivation of C. burnetii and C. burnetii spores in clean fluids; (iii) the inactivation of C. burnetii and C. burnetii spores on complex materials and in manure; and (iv) the inactivation of C. burnetii and C. burnetii spores on complex surfaces.

Other acts of the same type
Council Decision (EU) 2024/2820 of 24 October 2024 on the position to be taken on behalf of the European Union at the 233rd session of the Council of the International Civil Aviation Organization as regards the adoption of Amendment 30 to Annex 9 — Facilitation — to the Convention on International Civil Aviation concerning amendments to Chapters 2, 3 and 6 and to Chapter 8, paragraphs C, E, F and G, of that AnnexCouncil Decision (EU) 2024/2824 of 24 October 2024 on the position to be taken on behalf of the European Union at the 233rd session of the Council of the International Civil Aviation Organization as regards the adoption of Amendment 30 to Annex 9 – Facilitation – to the Convention on International Civil Aviation concerning amendments to Chapter 1, Chapter 3, paragraphs C, D, G and H, and Chapter 8, paragraphs H and I, of that AnnexCommission Implementing Decision (EU) 2024/2712 of 23 October 2024 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Phenogen in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2024) 7275)Decision (ΕU) 2024/2829 of the European Parliament and of the Council of 23 October 2024 amending Directive 2007/2/EC as regards certain reporting requirements for infrastructures for spatial information (Text with EEA relevance)Decision (EU) 2024/2854 of the European Parliament and of the Council of 23 October 2024 on the mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Belgium – EGF/2024/001 BE/Match-SmatchCommission Decision (EU) 2025/62 of 23 October 2024 on the aid schemes SA.56908 (2023/C) (ex 2020/N) – Prolongation and modification of biogas scheme for motor fuel in Sweden and SA.56125 (2023/C) (ex 2020/N) – Prolongation and modification of scheme SA.49893 (2018/N) – Tax exemption for non-food-based biogas and bio-propane in heat generation implemented by Sweden (notified under document C(2024) 7313)Council Decision (CFSP) 2024/2722 of 21 October 2024 amending Decision (CFSP) 2015/1763 concerning restrictive measures in view of the situation in BurundiCouncil Decision (CFSP) 2024/2723 of 21 October 2024 amending Decision (CFSP) 2019/2110 on the European Union CSDP Advisory Mission in the Central African Republic (EUAM RCA)Council Decision (EU) 2024/2734 of 21 October 2024 on the financial contributions to be paid by the parties to the European Development Fund as a third instalment for 2024Commission Implementing Decision (EU) 2024/2743 of 21 October 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2024) 7450)Council Decision (EU) 2024/3029 of 21 October 2024 on the position to be taken on behalf of the European Union within the EU-CTC Joint Committee established by the Convention on the simplification of formalities in trade in goods and within the EU-CTC Joint Committee established by the Convention on a common transit procedure as regards invitations to Georgia to accede to those ConventionsDecision No S12 of 16 October 2024 concerning the reimbursement of healthcare in connection to patients’ transfer to another Member State in case of mass casualties following disasters

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next